J.P. Morgan: Financing Tech & AI in the Healthcare Sector

J.P. Morgan is one of the largest financial services firms in the world, with assets of US$3.9tn globally.

Its teams of commercial and investment bankers and specialists provide expertise for professionals across many industries, including retail, energy and healthcare.

In the healthcare sector, J.P. Morgan gives insights and support to help develop and grow organisations, with specialist knowledge on embedding AI and other technologies into operations.

Serving the healthcare sector

J.P. Morgan supports healthcare organisations with solutions to help build financial strength, resilience and growth.

It can help healthcare providers in the transition to a digital-first healthcare landscape, by providing solutions to keep patient information safe and prevent fraud.

J.P. Morgan’s solutions can also help deliver payments and digital solutions for employers, as well as simplifying billing and insurance communications while eliminating the need for paper-based processes.

InstaMed, part of J.P Morgan’s healthcare payments business, helps support clients with end-to-end payments, treasury and banking solutions.

It uses J.P Morgan’s cloud-based technology to create electronic transactions, process payments and move healthcare data smoothly and safely.

InstaMed can help healthcare organisations remove waste and inefficiencies from the payment process, which allows time and cost savings to be reinvested into caring for patients and investing in technology and research.

Jeff Lin, CEO of InstaMed, says: “In an era where healthcare organisations are deeply linked with a broad network of partners, robust cybersecurity is no longer optional – it’s essential.

“Extending protections to vendors, clients and suppliers is critical to maintaining trust and operational integrity.”

Biotechnology solutions

Within the healthcare industry, J.P. Morgan offers specialist solutions for life sciences companies, including in biotechnology and pharmaceuticals.

Its bankers support start-ups, pre-clinical stages of development and commercialisation.

It can share expertise when it comes to financial and regulatory challenges that companies face within the sector.

J.P. Morgan connects clients with experts around the world, helping life sciences companies manage their international operations.

It helps companies with unique needs related to subsectors of the industry, including medical devices, diagnostics and biopharmaceuticals.

Through its digital platforms, J.P. Morgan allows companies to evolve and grow in the healthcare sector by increasing their efficiency, reducing costs, saving time and being able to make more informed decisions in their operations.

J.P. Morgan’s Healthcare Advisory Council

In December 2025, leaders in the US healthcare sector came together at J.P. Morgan’s Healthcare Advisory Council.

At the event, the impact of AI on the industry was discussed, showing how it can be practically implemented into healthcare settings.

For example, Hartford Healthcare, which operates multiple hospitals and specialist facilities across the US, has partnered with MIT to develop an AI platform.

The collaboration created practical solutions, including an emergency department scheduling system, as well as a platform that analyses patient data.

This platform was proven to reduce the length of patients’ stay by one full day across six hospitals in Connecticut.

Hartford Healthcare used an AI tool for clinical documentation across physician practices.

When implemented into a real life healthcare setting, the technology reduced the burden of documentation on staff, while keeping detailed records, meaning physicians had more time to focus on patient care.

“This is the best time we’ve ever had in healthcare,” Jeff Flaks, CEO of Hartford HealthCare, says. “You can get better, faster, now.

“The types of improvements we’re able to do with AI and machine-based learning and the ability to intervene quickly to make significant improvements is different today than ever before.”